Former users, however, do not seem to face the same risks as current users. 

Devi Nair, MD, director of cardiac electrophysiology at St. Bernard's Healthcare, Jonesboro, Arkansas, explains some of the recent advances in transcatheter left atrial appendage (LAA) occlusion technology at the 2022 Transcatheter Valve Therapeutics (TVT) Structural Heart Summit.

Researchers studied data from more than three million patients, including approximately 76,000 who underwent heart surgery.

The additional costs associated with AFib ablation appear to be justified, researchers wrote.

The new software solution was designed with ventricular tachycardia ablation and other cardiac ablation procedures in mind.